CERVOMED INC (CRVO) Soars 10.6%: Is Further Upside Left in the Stock?

Zacks09-20

CervoMed Inc. (CRVO) shares ended the last trading session 10.6% higher at $17.47. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2468008611?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/MOIrCfP73.h_oNu1hTnqhg--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a6dd2d75214496e555b9303c8a13c0ef","is_english":true,"pubTime":"2024-09-20 15:37","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2468008611","market":"us","top_or_hot":-1,"title":"CERVOMED INC (CRVO) Soars 10.6%: Is Further Upside Left in the Stock?","media":"Zacks","content":"<div>\n<p>CervoMed Inc. (CRVO) shares ended the last trading session 10.6% higher at $17.47. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This...</p>\n\n<a href=\"https://finance.yahoo.com/news/cervomed-inc-crvo-soars-10-073700744.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CERVOMED INC (CRVO) Soars 10.6%: Is Further Upside Left in the Stock?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCERVOMED INC (CRVO) Soars 10.6%: Is Further Upside Left in the Stock?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-20 15:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/cervomed-inc-crvo-soars-10-073700744.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>CervoMed Inc. (CRVO) shares ended the last trading session 10.6% higher at $17.47. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This...</p>\n\n<a href=\"https://finance.yahoo.com/news/cervomed-inc-crvo-soars-10-073700744.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CMVLF","symbol_name":"Cellectis Romainville","start_time":0,"source_url":"https://finance.yahoo.com/news/cervomed-inc-crvo-soars-10-073700744.html","article_id":"2468008611","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/MOIrCfP73.h_oNu1hTnqhg--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a6dd2d75214496e555b9303c8a13c0ef"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2468008611","pubTimestamp":1726817820,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"CervoMed Inc.  shares ended the last trading session 10.6% higher at $17.47. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 2.3% loss over the past four weeks.Last month, the company reported robust financial results for the second quarter of 2024. The phase IIb study evaluating CervoMed’s pipeline candidate, neflamapimod, for treating Dementia with Lewy Bodies is also progressing well. This might have driven the share price rally.This company is expected to post quarterly loss of $0.41 per share in its upcoming report, which represents a year-over-year change of +41.4%. Revenues are expected to be $1.75 million, up 14.4% from the year-ago quarter.For CERVOMED INC, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an ey","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"CMVLF":"Cellectis Romainville","INC":"VANECK DYNAMIC HIGH INCOME ETF","CRVO":"CervoMed","BK4139":"生物科技","CLLS":"Cellectis S.A."},"translate_title":"CERVOMED INC(CRVO)飙升10.6%：该股还有进一步上涨的空间吗？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CLLS":1,"CRVO":1,"INC":1,"CMVLF":0.9},"content_text":"CervoMed Inc. (CRVO) shares ended the last trading session 10.6% higher at $17.47. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 2.3% loss over the past four weeks.\nLast month, the company reported robust financial results for the second quarter of 2024. The phase IIb study evaluating CervoMed’s pipeline candidate, neflamapimod, for treating Dementia with Lewy Bodies is also progressing well. This might have driven the share price rally.\nThis company is expected to post quarterly loss of $0.41 per share in its upcoming report, which represents a year-over-year change of +41.4%. Revenues are expected to be $1.75 million, up 14.4% from the year-ago quarter.\nEarnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.\nFor CERVOMED INC, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on CRVO going forward to see if this recent jump can turn into more strength down the road.\nThe stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>\nCERVOMED INC is part of the Zacks Medical - Biomedical and Genetics industry. Cellectis S.A. (CLLS), another stock in the same industry, closed the last trading session 1.8% higher at $2.32. CLLS has returned -3.2% in the past month.\nFor Cellectis , the consensus EPS estimate for the upcoming report has remained unchanged over the past month at -$0.20. This represents a change of +35.5% from what the company reported a year ago. Cellectis currently has a Zacks Rank of #3 (Hold).\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report\nCervoMed Inc. (CRVO) : Free Stock Analysis Report\nCellectis S.A. (CLLS) : Free Stock Analysis Report\nTo read this article on Zacks.com click here.\nZacks Investment Research","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2468008611"}